MATERIAL SAFETY DATA SHEET
SHANNON SLI-5230, LIQUID
3. HAZARDS IDENTIFICATION
Harmful if inhaled, absorbed through skin, or swallowed. Causes skin irritation. Causes severe eye
irritation. High vapour concentrations may cause drowsiness. See "Other Health Effects" Section. Can
decompose at high temperatures forming toxic gases. Contents may develop pressure on prolonged
exposure to heat.
EMERGENCY OVERVIEW:
POTENTIAL HEALTH EFFECTS
Contact with mist or spray will cause irritation of mucous membranes, coughing and difficulty in
breathing. See "Other Health Effects" Section.
Inhalation:
EMERGENCY TELEPHONE NUMBERS (FOR EMERGENCIES INVOLVING CHEMICAL SPILLS OR RELEASE)
Toronto, ON (416) 226-6117 Montreal, QC (514) 861-1211 Winnipeg, MB (204) 943-8827
Edmonton, AB (780) 424-1754 Calgary, AB (403) 263-8660 Vancouver, BC (604) 685-5036
1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
Brenntag Canada Inc.
43 Jutland Rd.
Toronto, ON
M8Z 2G6
(416) 259-8231
Website: http:\\www.brenntag.ca
WHMIS#:
00064756
Index:
2008 May 14
PRODUCT IDENTIFICATION
Shannon SLI-5230, Liquid.
Product Name:
2008 May 14
Date of Revision:
Effective Date:
HCI3578/08B
Not applicable.
Chemical Name:
S L I - 52 30.
Synonyms:
Inorganic Phosphate.
Chemical Family:
Not applicable.
Molecular Formula:
Corrosion Inhibitor. Water treatment. Anti-corrosion additive. Chemical intermediate.
Product Use:
WHMIS Classification / Symbol:
READ THE ENTIRE MSDS FOR THE COMPLETE HAZARD EVALUATION OF THIS PRODUCT.
D-2B: Toxic (skin and eye irritant)
Ingredient
CAS#
ACGIH TLV
% Concentration
2. COMPOSITION, INFORMATION ON INGREDIENTS (Not Intended As Specifications)
Monosodium Phosphate
7558-80-7
—
30 - 60
The identity of one or more of the
ingredient(s) of this product have not
been disclosed by our supplier(s) and
we are not aware of any additional
health hazards due to these ingredients,
which are not already identified on this
MSDS.

Shannon SLI-5230, Liquid
Brenntag Canada Inc.
Date of Revision:
2008 May 14
WHMIS Number :
00064756
Page 2 of 7
4. FIRST AID MEASURES
FIRST AID PROCEDURES
Move victim to fresh air. Give artificial respiration ONLY if breathing has stopped. Give
cardiopulmonary resuscitation (CPR) if there is no breathing AND no pulse. Obtain medical attention
IMMEDIATELY.
Inhalation:
Prompt removal of the material is essential. Flush skin with running water and wash affected areas
thoroughly with soap and water. Start flushing while removing contaminated clothing. Obtain medical
attention IMMEDIATELY.
Skin Contact:
Prompt removal of the material is essential. Immediately flush eyes with running water for a minimum of
20 minutes. Hold eyelids open during flushing. If irritation persists, repeat flushing. Obtain medical
attention IMMEDIATELY.
Eye Contact:
Do not attempt to give anything by mouth to an unconscious person. If victim is alert and not
convulsing, rinse mouth out and give 1/2 to 1 glass of water to dilute material. IMMEDIATELY contact
local Poison Control Centre. Vomiting should only be induced under the direction of a physician or a
poison control centre. If spontaneous vomiting occurs, have victim lean forward with head down to
avoid breathing in of vomitus, rinse mouth and administer more water. IMMEDIATELY transport victim
to an emergency facility.
Ingestion:
This product contains materials that may cause severe pneumonitis if aspirated. If ingestion has
occurred less than 2 hours earlier, carry out careful gastric lavage; use endotracheal cuff if available, to
prevent aspiration. Observe patient for respiratory difficulty from aspiration pneumonitis. Give artificial
resuscitation and appropriate chemotherapy if respiration is depressed.
Treatment of large quantity phosphate salts ingestion should take into consideration both anionic and
cation portion of the molecule. The following treatments should be considered for the specified group(s)
of the phosphate salts found in this product: All phosphate salts, except calcium salts, have a
hypothetical risk of hypocalcemia, so calcium levels should be monitored. Sodium salts have a
hypothetical risk of hypernatremia. In addition to calcium levels, sodium and phosphate levels should
be monitored.
Medical conditions that may be aggravated by exposure to this product include neurological and
cardiovascular disorders, diseases of the skin, eyes or respiratory tract, preexisting liver and kidney
disorders.
Note to Physicians:
Skin contact can cause irritation, especially under the finger nails (and other confined spaces such as
under rings or watch bands). May cause defatting, drying and cracking of the skin. Prolonged and
repeated contact may lead to dermatitis.
Skin Contact:
A single, prolonged skin exposure is not likely to result in the absorption of toxic amounts of the material.
Skin Absorption:
Vapours from this product are irritating to the eyes. Splashes to the eye may cause severe irritation,
redness and pain.
Eye Contact:
This product causes irritation, a burning sensation of the mouth and throat and abdominal pain.
Ingestion of large quantities of phosphate salts (over 1.0 grams for an adult) may cause an osmotic
catharsis resulting in diarrhea and probable abdominal cramps. Larger doses such as 4-8 grams will
almost certainly cause these effects in everyone. In healthy individuals most of the ingested salt will be
excreted in the feces with the diarrhea and, thus, not cause any systemic toxicity. Doses greater than
10 grams hypothetically may cause systemic toxicity. (3) Phosphate salts have been studied
extensively since they are used in food additives. Toxic effects on the kidney, parathyroid glands and
bones have been reported in experimental animals exposed to high oral doses. These high doses are
not considered relevant to occupational exposure. (4)
Ingestion:
Effects (irritancy) on the skin and eyes may be delayed, and damage may occur without the sensation
or onset of pain. Strict adherence to first aid measures following any exposure is essential.
Contains a phosphate salt. May cause kidney damage, hypocalcemic tetany and metabolic acidosis.
Signs and symptoms of kidney damage generally progress from oliguria, to blood in the urine, to total
renal failure. Metabolic acidosis is a condition that describes a decreased pH and bicarbonate
concentration in the body fluids. Since phosphates are slowly and incompletely absorbed [in the gut],
systemic reactions are unlikely when these salts are swallowed. Polyphosphates are thought to be
hydrolyzed to orthophosphates before absorption, which may induce a metabolic acidosis. If
appreciable amounts of the intact polymer are absorbed from the alimentary tract, hypocalcemic tetany
(muscular contraction, pains, tingling, etc., caused by a deficiency of calcium salts) may be a danger
due to the binding of ionized calcium. (3) All phosphate salts, except calcium salts, have a hypothetical
risk of hypocalcemia. (8) Sodium salts have a hypothetical risk of hypernatremia.
Other Health Effects:
Shannon SLI-5230, Liquid
Brenntag Canada Inc.
Date of Revision:
2008 May 14
WHMIS Number :
00064756
Page 3 of 7
5. FIRE-FIGHTING MEASURES
Flashpoint (°C)
AutoIgnition
Temperature (°C)
LEL
UEL
Flammability Limits in Air (%):
Does not flash.
Not applicable.
Not applicable.
Not applicable.
Not regulated.
Flammability Class (WHMIS):
Thermal decomposition products are toxic and may include oxides of sodium, phosphorus and irritating
gases.
Hazardous Combustion
Products:
Closed containers exposed to heat may burst. Spilled material may cause floors and contact surfaces
to become slippery.
Unusual Fire or Explosion
Hazards:
Not expected to be sensitive to mechanical impact.
Sensitivity to Mechanical Impact:
Not available.
Rate of Burning:
Not available.
Explosive Power:
Not expected to be sensitive to static discharge.
Sensitivity to Static Discharge:
EXTINGUISHING MEDIA
Use media appropriate for surrounding fire and/or materials.
Fire Extinguishing Media:
FIRE FIGHTING
INSTRUCTIONS
Use water spray to cool fire-exposed containers or structures. Use water spray to disperse vapours.
Isolate materials that are not involved in the fire and protect personnel.
Instructions to the Fire Fighters:
Use self-contained breathing apparatus and protective clothing.
Fire Fighting Protective
Equipment:
6. ACCIDENTAL RELEASE MEASURES
Information in this section is for responding to spills, leaks or releases in order to prevent or minimize the adverse effects on persons,
property and the environment. There may be specific reporting requirements associated with spills, leaks or releases, which change from
region to region.
In all cases of leak or spill contact vendor at Emergency Number shown on the front page of this MSDS.
Wear protective clothing. Eliminate all sources of ignition. Collect product for recovery or disposal. For
release to land, or storm water runoff, contain discharge by constructing dykes or applying inert
absorbent; for release to water, utilize damming and/or water diversion to minimize the spread of
contamination. Ventilate enclosed spaces. Notify applicable government authority if release is
reportable or could adversely affect the environment.
Containment and Clean-Up
Procedures:
7. HANDLING AND STORAGE
HANDLING
Use normal "good" industrial hygiene and housekeeping practices. Containers exposed to heat may be
under internal pressure. These should be cooled and carefully vented before opening. A face shield
and apron should be worn. Vent container frequently, and more often in warm weather, to relieve
pressure.
Handling Practices:
See Section 8, "Engineering Controls".
Ventilation Requirements:
Use only with adequate ventilation and avoid breathing aerosols ( vapours or mists ). Avoid contact with
eyes, skin or clothing. Wash thoroughly with soap and water after handling. Wash contaminated
clothing thoroughly before re-use. Do not use cutting or welding torches on empty drums that contained
this material/product.
Other Precautions:
STORAGE
See below.
Storage Temperature (°C):
Ventilation should be corrosion proof.
Ventilation Requirements:
Store in a cool, well-ventilated area. Keep away from heat, sparks and flames. Keep containers
closed. Do not expose sealed containers to temperatures above 40° C. Avoid freezing! Protect from
direct sunlight. Protect against physical damage.
Storage Requirements:
Shannon SLI-5230, Liquid
Brenntag Canada Inc.
Date of Revision:
2008 May 14
WHMIS Number :
00064756
Page 4 of 7
Equipment for storage, handling or transport should NOT be made from the following material, or,
where applicable, its alloys: zinc, black iron, brass, aluminum, mild steel, lead and bronze. Confirm
suitability of any material before using.
Special Materials to be Used for
Packaging or Containers:
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Recommendations listed in this section indicate the type of equipment, which will provide protection against overexposure to this
product. Conditions of use, adequacy of engineering or other control measures, and actual exposures will dictate the need for specific
protective devices at your workplace.
ENGINEERING CONTROLS
Local exhaust ventilation required. Ventilation should be corrosion proof. Make up air should be
supplied to balance air that is removed by local or general exhaust ventilation. Ventilate low lying areas
such as sumps or pits where dense vapours may collect.
Engineering Controls:
PERSONAL PROTECTIVE
EQUIPMENT (PPE)
Safety glasses with side shields are recommended to prevent eye contact. Use chemical safety goggles
when there is potential for eye contact. Contact lenses should not be worn when working with this
material.
Eye Protection:
Gloves and protective clothing made from neoprene should be impervious under conditions of use.
Prior to use, user should confirm impermeability. Discard contaminated gloves.
Skin Protection:
No specific guidelines available. A NIOSH/MSHA-approved air-purifying respirator equipped with dust,
mist, fume cartridges for concentrations up to 1, 000 ppm. An air-supplied respirator if concentrations
are higher or unknown.
Respiratory Protection:
Wear regular work clothing. Locate safety shower and eyewash station close to chemical handling area.
Take all precautions to avoid personal contact.
Other Personal Protective
Equipment:
None established for this product.
EXPOSURE GUIDELINES
Liquid.
Clear, water-white liquid.
Odourless.
Not available.
Not available.
-7. (3)
Not available.
Not available.
1.3 - 1.4. (3)
1 300 - 1 400 kg/m³
Not available.
Not available.
Soluble in water.
Not available.
5.6 - 6.2. (3)
Not available.
Not available.
Physical State:
Appearance:
Odour:
Odour Threshold (ppm):
Boiling Range (°C):
Melting/Freezing Point (°C):
Vapour Pressure (mm Hg at 20° C):
Vapour Density (Air = 1.0):
Relative Density (g/cc):
Bulk Density:
Viscosity:
Evaporation Rate (Butyl Acetate = 1.0):
Solubility:
% Volatile by Volume:
pH:
Coefficient of Water/Oil Distribution:
Volatile Organic Compounds (VOC):
9. PHYSICAL AND CHEMICAL PROPERTIES (Not intended as Specifications)
Does not flash.
Flashpoint (°C):
10. STABILITY AND REACTIVITY
CHEMICAL STABILITY
Stable.
Under Normal Conditions:
Not flammable.
Under Fire Conditions:
Shannon SLI-5230, Liquid
Brenntag Canada Inc.
Date of Revision:
2008 May 14
WHMIS Number :
00064756
Page 5 of 7
11. TOXICOLOGICAL INFORMATION
TOXICOLOGICAL DATA:
SUBSTANCE
LD50 (Oral, Rat)
LD50 (Dermal, Rabbit)
LC50 (Inhalation, Rat, 4h)
Monosodium Phosphate
8 290 mg/kg (1)
---
---
The ingredient(s) of this product is (are) not classed as carcinogenic by ACGIH, IARC, OSHA or NTP.
Carcinogenicity Data:
No adverse reproductive effects are anticipated.
Reproductive Data:
Mutagenicity tests have been negative or inconclusive.
Mutagenicity Data:
No adverse teratogenic effects are anticipated.
Teratogenicity Data:
None known.
Respiratory / Skin Sensitization
Data:
None known.
Synergistic Materials:
Mild irritation, based on animal and human information. Mild irritation resulted from exposure to 50 mg
for 24 hours in a Standardized Draize test using human volunteers. (4)
A two and a half year old girl received two enemas consisting of sodium dihydrogen phosphate (3.7
g/phosphorus/each) in 67.5 mL of water. She developed marked hyperphosphatemia, hypernatremia,
hypocalcemia and acidosis. Symptoms, consisting of vomiting, lethargy, hyperpyrexia, diarrhea, carpal
spasm and coma, began after 90 minutes and were eventual relieved by the administration of calcium
gluconate. (4)
No adverse effects were reported after ingestion of 5 to 7 grams per day by humans for varying periods
of time. No apparent adverse effects resulted from the ingestion of 6 grams for 15 days by 2 adults. (4)
Diarrhea resulted from administration of 250,000 mg/Kg of Monosodium Phosphate in rats, guinea pigs
and rabbits. (4)
No differences were observed compared to non-exposed animals after ingestion of up to 370 mg/kg in
mice and up to 410 mg/kg in rats during pregnancy. These doses would not be expected to cause
maternal toxicity. (4)
A negative result was obtained in a bacterial assay, with and without metabolic activation. (4)
Other Studies Relevant to
Material:
12. ECOLOGICAL INFORMATION
Not available. May be harmful to aquatic life. Toxicity is primarily associated with pH.
Ecotoxicity:
Although a principal problem of phosphates in the environment is not directly related to human health,
there is considerable concern about the effects of phosphorous from various sources on water quality.
Phosphate is a major cause of the eutrophication process in lakes and ponds.
Eutrophication is a process where an ecosystem, rich in nutrients and therefore supporting a dense
plant population, kills animal life by depriving it of oxygen.
Inorganic phosphates in contact with the soil, sub-surface or surface waters may be taken up by plants
and utilized as essential nutrients. Phosphates may also form preciptates usually with calcium or
magnesium. The resultant compounds are insoluble in water and become a part of the soil or
sediment. The term biodegradability, as such, is not applicable to inorganic compounds. (3) Can be
dangerous if allowed to enter drinking water intakes. Do not contaminate domestic or irrigation water
supplies, lakes, streams, ponds, or rivers.
Environmental Fate:
Will not occur.
Hazardous Polymerization:
High temperatures, sparks, open flames and all other sources of ignition. Decompositon will occur
above 169 °C. ( 4 ) Keep from freezing. Keep tightly closed to protect quality. Avoid moisture
contamination.
Conditions to Avoid:
Strong oxidizers. Strong acids. Strong bases. Magnesium Methenamine. Contact with acids will liberate
Zinc and its alloys. Black iron. Brass. Aluminum and its alloys. Mild steel. Lead. Bronze. Concrete.
Cement.
Materials to Avoid:
Thermal decomposition products are toxic and may include oxides of sodium, phosphorus and irritating
gases.
Decomposition or Combustion
Products:
Shannon SLI-5230, Liquid
Brenntag Canada Inc.
Date of Revision:
2008 May 14
WHMIS Number :
00064756
Page 6 of 7
13. DISPOSAL CONSIDERATIONS
None required.
Deactivating Chemicals:
This information applies to the material as manufactured. Reevaluation of the product may be required
by the user at the time of disposal since the product uses, transformations, mixtures and processes
may influence waste classification. Dispose of waste material at an approved (hazardous) waste
treatment/disposal facility in accordance with applicable local, provincial and federal regulations. Do not
dispose of waste with normal garbage, or to sewer systems.
Waste Disposal Methods:
See "Waste Disposal Methods".
Safe Handling of Residues:
Empty containers retain product residue (liquid and/or vapour) and can be dangerous. Empty drums
should be completely drained, properly bunged and promptly returned to a drum reconditioner. Dispose
of waste material at an approved (hazardous) waste treatment/disposal facility or waste incineration
facility in accordance with applicable local, provincial and federal regulations.
Disposal of Packaging:
14. TRANSPORTATION INFORMATION
CANADIAN TDG ACT SHIPPING DESCRIPTION:
This product is not regulated by TDG.
Label(s): Not applicable. Placard: Not applicable.
ERAP Index: -----.
Exemptions: None known.
US DOT CLASSIFICATION (49CFR 172.101, 172.102):
This product is not regulated by DOT.
Label(s): Not applicable. Placard: Not applicable.
CERCLA-RQ: Not available.
Exemptions: None known.
15. REGULATORY INFORMATION
CANADA
All constituents of this product are included on the DSL.
CEPA - NSNR:
Not included.
CEPA - NPRI:
Controlled Products Regulations Classification (WHMIS):
D-2B: Toxic (skin and eye irritant)
USA
All constituents of this product are included on the TSCA inventory.
Environmental Protection Act:
Skin and Eye Irritant
OSHA HCS (29CFR 1910.1200):
Text22:
NFPA: 0 Health, 0 Fire, 0 Reactivity (3)
Text22:
HMIS: 1 Health, 0 Fire, 0 Reactivity (6)
INTERNATIONAL
: Not available.
16. OTHER INFORMATION
REFERENCES
RTECS-Registry of Toxic Effects of Chemical Substances, Canadian Centre for Occupational Health and Safety RTECS
database.
1.
Clayton, G.D. and Clayton, F.E., Eds., Patty's Industrial Hygiene and Toxicology, 3rd ed., Vol. IIA,B,C, John Wiley and Sons,
New York, 1981.
2.
Supplier's Material Safety Data Sheet(s).
3.
CHEMINFO, through "CCINFOdisc", Canadian Centre for Occupational Health and Safety, Hamilton, Ontario, Canada.
4.
Guide to Occupational Exposure Values, 2007, American Conference of Governmental Industrial Hygienists, Cincinnati, 2007.
5.
Shannon SLI-5230, Liquid
Brenntag Canada Inc.
Date of Revision:
2008 May 14
WHMIS Number :
00064756
Page 7 of 7
Regulatory Affairs Group, Brenntag Canada Inc.
6.
The British Columbia Drug and Poison Information Centre, Poison Managements Manual, Canadian Pharmaceutical
Association, Ottawa, 1981.
7.
____________________________________________________________________________________________________________
The information contained herein is offered only as a guide to the handling of this specific material and has been prepared in good faith
by technically knowledgeable personnel. It is not intended to be all-inclusive and the manner and conditions of use and handling may
involve other and additional considerations. No warranty of any kind is given or implied and Brenntag Canada Inc. will not be liable for
any damages, losses, injuries or consequential damages which may result from the use of or reliance on any information contained
herein. This Material Safety Data Sheet is valid for three years.
____________________________________________________________________________________________________________
To obtain revised copies of this or other Material Safety Data Sheets, contact your nearest Brenntag Canada Regional office.
British Columbia: 20333-102B Avenue, Langley, BC, V1M 3H1
Phone: (604) 513-9009 Facsimile: (604) 513-9010
Alberta: 6628 - 45 th. Street, Leduc, AB, T9E 7C9
Phone: (780) 986-4544 Facsimile: (780) 986-1070
Manitoba: 681 Plinquet Street, Winnipeg, MB, R2J 2X2
Phone: (204) 233-3416 Facsimile: (204) 233-7005
Ontario: 43 Jutland Road, Toronto, ON, M8Z 2G6
Phone: (416) 259-8231 Facsimile: (416) 259-5333
Quebec: 2900 Jean Baptiste Des., Lachine, PQ, H8T 1C8
Phone: (514) 636-9230 Facsimile: (514) 636-0877
Atlantic: A-105 Akerley Boulevard, Dartmouth, NS, B3B 1R7
Phone: (902) 468-9690 Facsimile: (902) 468-3085
____________________________________________________________________________________________________________
Prepared By: Regulatory Affairs Group, Brenntag Canada Inc., (416) 259-8231.